Since administration of WVDC-2109 correlates with an increase in bacterial clearance, we speculate that the lower levels of circulating cytokines in response to infection present in mice treated with WVDC-2109 are associated with a greater control of bacterial burden rather than interference with TLR5 signaling. The gene discussed is TLR5; the disease is infection.